This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Alchemia Limited, The University of Queensland, Vast Bioscience Pty Limited. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Queensland, AU (2011)
- Wynnum, AU (2011 - 2022)
Company Filing History:
3 out of 15 
2 out of 345 
1 out of 1 Years Active: 2011-2025
Title: Biography of Inventor Johannes Zuegg
Introduction: Johannes Zuegg is a notable inventor based in Wynnum, Australia. He has made significant contributions to the field of medical research, particularly in the development of compounds for treating various diseases.
Latest Patents: Johannes Zuegg holds six patents, with his latest inventions focusing on compounds that inhibit SOX18 protein activity. These compounds show efficacy in treating angiogenesis- and lymphangiogenesis-related diseases, including cancer metastasis and vascular cancers.
Career Highlights: Throughout his career, Johannes has worked with prominent organizations such as Alchemia Limited and the University of Queensland. His work has been instrumental in advancing medical treatments and understanding complex biological processes.
Collaborations: Johannes has collaborated with esteemed colleagues, including Wim F Meutermans and Gerald B Tometzki. These partnerships have enhanced his research and contributed to the success of his inventions.
Conclusion: Johannes Zuegg's innovative work and dedication to medical research have established him as a significant figure in his field. His contributions continue to impact the treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile